Leaman John Harold 4
4 · IMPEL PHARMACEUTICALS INC · Filed Jan 4, 2023
Insider Transaction Report
Form 4
Leaman John Harold
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2022-12-31+10,571→ 10,571 total - Tax Payment
Common Stock
2022-12-31$3.75/sh−3,627$13,601→ 6,944 total - Exercise/Conversion
Restricted Stock Units (RSUs)
2022-12-31−10,571→ 0 total→ Common Stock (10,571 underlying)
Footnotes (4)
- [F1]Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units ("RSUs") and does not represent a sale by the reporting person.
- [F2]Each RSU represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement.
- [F3]The RSUs vest as to 100% of the total shares on December 31, 2022, subject to the Reporting Person's continuation of employment on such vesting date.
- [F4]RSUs do not expire; they either vest or are canceled prior to the vesting date.